A new pill that combats antibiotic-resistant strains of gonorrhoea has inched closer to approval in the US, after the US Food and Drug Administration (FDA) accepted GSK’s gepotidacin for priority ...

[FDA headquarters in Washington DC.] JHVEPhoto GSK (NYSE:GSK [https://seekingalpha.com/symbol/GSK]) announced on Monday that ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...